COVID-19 MORTALITY CASES IN KUBANG PASU DISTRICT
COVID-19 has rapidly impacted on mortality worldwide. Early identification of COVID-19 cases in community at high risk of death can enhance patient treatment and resource allocation. The goal of this study is to identify the characteristics of COVID-19 mortality cases in Kubang Pasu districts in 2021. Data on mortality cases in the year 2021 in Kubang Pasu district were collected, extracted and analyzed. There are 210 (1.9%) mortality cases had been recorded in 2021 due to COVID-19 infection form 11019 COVID-19 cases in Kubang Pasu district. The mortality cases consist of 108(51%) female and 102(49%) male. The highest mortality cases involved the age group of more than 70 years old with 73 (34.8%) cases. The highest race was Malay 193(91.9%), followed by non-Malaysian(2.9%), Chinese 4(1.9%), Siamese 4(1.9%) and Indian 3(1.4%) respectively. Most of the mortality cases are unvaccinated 153 (72.9%). The most coomon cause of death is due to COVID-19 pneumonia with 205 (97.5%) cases. Majority of the cases were screen through symptomatic screening and close contact screening 86 (40.9%) cases and 52 (24.8%) respectively. Among the mortality cases, there are 22(10.5%) brought-in-death cases which 19 (86%) cases are Malay. Most of the brought-in-death cases are unvaccinated, 19 (86%) cases, incomplete vaccine 1 (5%) case and 2 (9%) cases completed vaccine. The highest number of mortality cases occur among those with age more than 70. It involved mostly among Malay race and they were unvaccinated. Lung complication is the main cause of death since most of the mortality cases passed away due to pneumonia. This high number of mortality and BID cases might be attributed to poor health-seeking behaviour among the Kubang Pasu population with COVID-19. Promotion activities about COVID-19 and vaccine should be strengthened further to improve the knowledge and actions towards COVID-19 in community.
Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 2020; 20(5):533–34. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19. Erratum in: Lancet Infect Dis. 2020 Sep;20(9):e215.
Friedman J, Liu P, Troeger CE, et al. Predictive performance of international COVID-19 mortality forecasting models. Nat Commun 2021; 12(1):2609. doi: 10.1038/s41467-021-22457-w.
Statista. Malaysia: COVID-19 total cases 2022 [Internet]. 2022 [updated 2022 March 18; cited 2022 March 23]. Available from https://www.statista.com/statistics/1183748/malaysia-COVID-19-total-cases/
UNICEF. COVID-19 confirmed cases and deaths [Internet]. 2022 [2022 March 21; cited 2022 June 15]. Available from https://data.unicef.org/resources/COVID-19-confirmed-cases-and-deaths-dashboard/
5. Ministry of Health Malaysia. Case definition of COVID-19. 2020 [updated 2020 March 24; cited 2022 January 3]. Available from https://www.moh.gov.my/moh/resources/Penerbitan/Garis% 20Panduan/COVID19/Annex_1_case_definition_COVID_22032020.pdf
Ministry of Health Malaysia. Annex 2e: Clinical management of confirmed COVID-19 case in adult and paediatric. 2021 [updated 2022 May 31; cited 2022 January 12]. Available from https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX-2E-CLINICAL-MANAGEMENT-OF-CONFIRMED-COVID-19-31052022.pdf
Birhane M, Bressler S, Gregory Chang G,et al. COVID-19 vaccine breakthrough infections reported to CDC—United States, January 1–April 30, 2021. MMWR Morb Mortal Wkly Rep 2021; 70(21):792–93. https://www.cdc.gov/mmwr/volumes/70/wr/mm7021e3.htm
Demombynes G. COVID-19 age-mortality curves are flatter in developing countries. Policy Research Working Paper No. 9313. World Bank, Washington, DC. 2020 [cited 2022 January 10]. https://openknowledge.worldbank.org/handle/10986/34028
Imam Z, Odish F, Gill I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020;288(4):469–76. doi: 10.1111/joim.13119.
Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother 2020;52(2):154–64. doi: 10.3947/ic.2020.52.2.154.
Glatman-Freedman A, Bromberg M, Dichtiar R, et al. The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data. EBioMedicine 2021;72:103574. doi: 10.1016/j.ebiom.2021.103574.
MacIntyre CR. Global spread of COVID-19 and pandemic potential. Global Biosecur 2020;2(1). DOI: http://doi.org/10.31646/gbio.55
Latunji OO, Akinyemi OO. Factors influencing health-seeking behaviour among civil servants in Ibadan, Nigeria. Ann Ib Postgrad Med 2018;16(1):52–60.